BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10212118)

  • 1. Potent, highly selective, and non-thiol inhibitors of protein geranylgeranyltransferase-I.
    Vasudevan A; Qian Y; Vogt A; Blaskovich MA; Ohkanda J; Sebti SM; Hamilton AD
    J Med Chem; 1999 Apr; 42(8):1333-40. PubMed ID: 10212118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of potent, highly-selective, 3-aryl-piperazinone inhibitors of protein geranylgeranyltransferase-I.
    Peng H; Carrico D; Thai V; Blaskovich M; Bucher C; Pusateri EE; Sebti SM; Hamilton AD
    Org Biomol Chem; 2006 May; 4(9):1768-84. PubMed ID: 16633570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and evaluation of potent and selective benzoyleneurea-based inhibitors of protein geranylgeranyltransferase-I.
    Carrico D; Blaskovich MA; Bucher CJ; Sebti SM; Hamilton AD
    Bioorg Med Chem; 2005 Feb; 13(3):677-88. PubMed ID: 15653335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of non-peptide Ras CAAX mimetics as potent farnesyltransferase inhibitors.
    Qian Y; Vogt A; Sebti SM; Hamilton AD
    J Med Chem; 1996 Jan; 39(1):217-23. PubMed ID: 8568811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent and selective non-cysteine-containing inhibitors of protein farnesyltransferase.
    Augeri DJ; O'Connor SJ; Janowick D; Szczepankiewicz B; Sullivan G; Larsen J; Kalvin D; Cohen J; Devine E; Zhang H; Cherian S; Saeed B; Ng SC; Rosenberg S
    J Med Chem; 1998 Oct; 41(22):4288-300. PubMed ID: 9784104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of type-I geranylgeranyltransferase in vitro and in whole cells by CAAL peptidomimetics.
    Qian Y; Vogt A; Vasudevan A; Sebti SM; Hamilton AD
    Bioorg Med Chem; 1998 Mar; 6(3):293-9. PubMed ID: 9568283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase.
    Ohkanda J; Strickland CL; Blaskovich MA; Carrico D; Lockman JW; Vogt A; Bucher CJ; Sun J; Qian Y; Knowles D; Pusateri EE; Sebti SM; Hamilton AD
    Org Biomol Chem; 2006 Feb; 4(3):482-92. PubMed ID: 16446806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-thiol farnesyltransferase inhibitors: evaluation of different AA(X)-peptidomimetic substructures in combination with arylic cysteine replacements.
    Sakowski J; Böhm M; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2002 Apr; 335(4):135-42. PubMed ID: 12112033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and in vivo analysis of potent non-thiol inhibitors of farnesyl protein transferase.
    Anthony NJ; Gomez RP; Schaber MD; Mosser SD; Hamilton KA; O'Neil TJ; Koblan KS; Graham SL; Hartman GD; Shah D; Rands E; Kohl NE; Gibbs JB; Oliff AI
    J Med Chem; 1999 Aug; 42(17):3356-68. PubMed ID: 10464022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of potential bisubstrate inhibitors of protein farnesyltransferase. Design and synthesis of functionalized imidazoles.
    de Figueiredo RM; Coudray L; Dubois J
    Org Biomol Chem; 2007 Oct; 5(20):3299-309. PubMed ID: 17912382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geranylgeranyl diphosphate-based inhibitors of post-translational geranylgeranylation of cellular proteins.
    Macchia M; Jannitti N; Gervasi G; Danesi R
    J Med Chem; 1996 Mar; 39(7):1352-6. PubMed ID: 8691464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agents.
    Ohkanda J; Buckner FS; Lockman JW; Yokoyama K; Carrico D; Eastman R; de Luca-Fradley K; Davies W; Croft SL; Van Voorhis WC; Gelb MH; Sebti SM; Hamilton AD
    J Med Chem; 2004 Jan; 47(2):432-45. PubMed ID: 14711313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A non-peptide mimetic of Ras-CAAX: selective inhibition of farnesyltransferase and Ras processing.
    Vogt A; Qian Y; Blaskovich MA; Fossum RD; Hamilton AD; Sebti SM
    J Biol Chem; 1995 Jan; 270(2):660-4. PubMed ID: 7822292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazole- and imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase.
    Bolchi C; Pallavicini M; Bernini SK; Chiodini G; Corsini A; Ferri N; Fumagalli L; Straniero V; Valoti E
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5408-12. PubMed ID: 21802946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-thiol farnesyltransferase inhibitors: utilization of the far aryl binding site by 5-cinnamoylaminobenzophenones.
    Mitsch A; Wissner P; Böhm M; Silber K; Klebe G; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2004 Sep; 337(9):493-501. PubMed ID: 15362122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Ras prenylation: a signaling target for novel anti-cancer drug design.
    Lerner EC; Hamilton AD; Sebti SM
    Anticancer Drug Des; 1997 Jun; 12(4):229-38. PubMed ID: 9199657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isothiazole dioxide derivative 6n inhibits vascular smooth muscle cell proliferation and protein farnesylation.
    Ferri N; Clerici F; Yokoyama K; Pocar D; Corsini A
    Biochem Pharmacol; 2005 Dec; 70(12):1735-43. PubMed ID: 16257390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of piperidine farnesyltransferase inhibitors with reduced glucuronidation potential.
    Tanaka R; Rubio A; Harn NK; Gernert D; Grese TA; Eishima J; Hara M; Yoda N; Ohashi R; Kuwabara T; Soga S; Akinaga S; Nara S; Kanda Y
    Bioorg Med Chem; 2007 Feb; 15(3):1363-82. PubMed ID: 17127066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and pharmacological evaluation of new farnesyl protein transferase inhibitors.
    Houssin R; Pommery J; Salaün MC; Deweer S; Goossens JF; Chavatte P; Hénichart JP
    J Med Chem; 2002 Jan; 45(2):533-6. PubMed ID: 11784157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.